Jeremy Clarkson, the British television presenter and writer, has announced he is in remission following treatment for an aggressive form of prostate cancer. The diagnosis came less than a year after he underwent emergency heart surgery, marking a challenging period for the 66-year-old.

Clarkson revealed that his cancer was detected in May 2025 during a routine medical examination, when blood tests showed elevated prostate-specific antigen (PSA) levels. Further testing, including the Stockholm3 test and an MRI scan, confirmed the presence of cancer confined within the prostate. His Gleason score, which measures prostate cancer severity, was classified as intermediate.

Instead of undergoing traditional treatments such as radiotherapy or complete prostate removal, Clarkson opted for high-intensity focused ultrasound (HIFU), a less invasive procedure that targets cancer cells with ultrasound energy while sparing surrounding tissue. The procedure involved an ultrasound probe inserted through the rectum under anesthesia. Although quick, Clarkson experienced considerable discomfort during recovery, including the use of a catheter, which he described as notably difficult to manage.

Complications arose after the treatment when Clarkson resumed blood thinner medication necessary for his earlier heart condition. This led to an emergency hospitalization due to severe side effects, an incident he detailed as "spectacularly painful." Nonetheless, follow-up PSA tests conducted two months ago showed no evidence of cancer, and Clarkson is now officially in remission. He remains under regular monitoring given the risk of recurrence, which affects up to 40% of prostate cancer patients.

Clarkson has been candid about the importance of early detection and urges men to undergo prostate cancer screening. He highlighted that in the UK, routine screening is generally limited to high-risk groups, meaning men without symptoms or family history, such as himself, may not be tested through NHS channels. Clarkson emphasized that early diagnosis dramatically improves survival rates, noting that untreated advanced prostate cancer sees a five-year survival rate of only 50%.

The presenter has joined a group of public figures, including former Prime Minister David Cameron and Soho House founder Nick Jones, to raise awareness about prostate cancer screening. Clarkson advocates for more accessible testing, suggesting that men could encourage doctors to administer PSA tests by reporting symptoms such as nocturnal urination.

His comments come amid ongoing debate about national screening protocols. The UK’s national screening committee recently advised against widespread prostate cancer screening due to concerns over false positives and overtreatment but approved targeted screening for select high-risk men. Clarkson criticized government efforts on the matter, calling for increased support and funding for prostate cancer detection.

Despite the health setbacks, Clarkson’s daily life has largely returned to normal. He follows a medication regimen related to his heart condition and has adopted a slower pace, engaging in walks and modifying his diet toward more vegetarian options. Clarkson also expressed determination to counter proposed inheritance tax changes affecting farming families, which he said he intends to address through unconventional means like cryogenics to ensure compliance with tax laws.

Clarkson’s experience underscores the challenges and complexities of prostate cancer management and highlights ongoing discussions about screening policies in the UK. He encourages men to undergo testing, emphasizing that early detection can be life-saving.